Related Experiment Video
Updated: Sep 25, 2026

Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways
Published on: January 13, 2016
Multiscale modeling of host-pathogen interactions and mucociliary clearance during non-tuberculous mycobacterial
Abstract:
Non-tuberculous mycobacterial (NTM) infections are a clinical challenge in cystic fibrosis (CF), where impaired mucociliary clearance and altered mucus rheology promote bacterial colonization despite host immune responses. Understanding how bacterial growth, immune cell dynamics, and mucus transport regulate infection progression is difficult because these processes interact across spatial and temporal scales. We develop a computational framework bridging a mechanistic agent-based model (ABM) of NTM infection with a spatially resolved partial differential equation (PDE) model. The PDE model couples bacterial proliferation, macrophage chemotaxis, immune-mediated clearance, mucus degradation, and viscoelastic transport in a two-compartment geometry representing mucus and lung tissue. Parameters are calibrated using data from the established ABM, yielding an efficient continuum representation while preserving cellular mechanisms. The PDE model reproduces bacterial and macrophage dynamics and enables analyses of mucus-related mechanisms and therapies. Sensitivity analysis identifies mucus viscosity, bacterial diffusivity, and macrophage mobility as key regulators of bacterial persistence through mucociliary clearance and tissue colonization. Simulations reveal nonlinear effects of mucolytic therapies: enhanced clearance reduces bacterial burden in mucus, whereas excessive viscosity reduction may promote migration into lung tissue, supporting combination with antibacterial treatment. This framework provides a quantitative platform for studying pulmonary infections, evaluating therapies, and developing patient-specific digital twins.
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Tuberculosis

